
Spinal intervention provides minimally invasive treatment for spine and nerve related painful conditions.
The global Spinal Intervention market is projected to reach US$ 22270 million in 2029, increasing from US$ 16210 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Spinal Intervention 91ÖÆÆ¬³§.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Spinal Intervention market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
BioControl Medical
Boston Scientific Corporation
Abbott
Synapse Biomedical
Zimmer Biomet Holdings
Stryker Corporation
Orthofix International
Globus Medical
DePuy Synthes
Astellas Pharma Inc.
BioWave Corporation
Vertebral Technologies, Inc.
CELGENE CORPORATION
Dr. Reddy's Laboratories Ltd.
Endo Pharmaceuticals Inc.
Johnson & Johnson Private Limited
Koninklijke Philips N.V.
Teva Pharmaceutical Industries Ltd.
Merck & Co Inc.
Pfizer Inc
Sanofi
SpineThera Inc.
Segment by Type
Open Surgery
Minimally Invasive Surgery
Segment by Application
Hospitals
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Spinal Intervention report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Intervention Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Open Surgery
1.2.3 Minimally Invasive Surgery
1.3 Market by Application
1.3.1 Global Spinal Intervention Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Research Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Intervention Market Perspective (2018-2029)
2.2 Spinal Intervention Growth Trends by Region
2.2.1 Global Spinal Intervention Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Spinal Intervention Historic Market Size by Region (2018-2023)
2.2.3 Spinal Intervention Forecasted Market Size by Region (2024-2029)
2.3 Spinal Intervention Market Dynamics
2.3.1 Spinal Intervention Industry Trends
2.3.2 Spinal Intervention Market Drivers
2.3.3 Spinal Intervention Market Challenges
2.3.4 Spinal Intervention Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Intervention Players by Revenue
3.1.1 Global Top Spinal Intervention Players by Revenue (2018-2023)
3.1.2 Global Spinal Intervention Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Intervention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Intervention Revenue
3.4 Global Spinal Intervention Market Concentration Ratio
3.4.1 Global Spinal Intervention Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Intervention Revenue in 2022
3.5 Spinal Intervention Key Players Head office and Area Served
3.6 Key Players Spinal Intervention Product Solution and Service
3.7 Date of Enter into Spinal Intervention Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Intervention Breakdown Data by Type
4.1 Global Spinal Intervention Historic Market Size by Type (2018-2023)
4.2 Global Spinal Intervention Forecasted Market Size by Type (2024-2029)
5 Spinal Intervention Breakdown Data by Application
5.1 Global Spinal Intervention Historic Market Size by Application (2018-2023)
5.2 Global Spinal Intervention Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Spinal Intervention Market Size (2018-2029)
6.2 North America Spinal Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Spinal Intervention Market Size by Country (2018-2023)
6.4 North America Spinal Intervention Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal Intervention Market Size (2018-2029)
7.2 Europe Spinal Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Spinal Intervention Market Size by Country (2018-2023)
7.4 Europe Spinal Intervention Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Intervention Market Size (2018-2029)
8.2 Asia-Pacific Spinal Intervention Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Spinal Intervention Market Size by Region (2018-2023)
8.4 Asia-Pacific Spinal Intervention Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal Intervention Market Size (2018-2029)
9.2 Latin America Spinal Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Spinal Intervention Market Size by Country (2018-2023)
9.4 Latin America Spinal Intervention Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Intervention Market Size (2018-2029)
10.2 Middle East & Africa Spinal Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Spinal Intervention Market Size by Country (2018-2023)
10.4 Middle East & Africa Spinal Intervention Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Spinal Intervention Introduction
11.1.4 Medtronic Revenue in Spinal Intervention Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 BioControl Medical
11.2.1 BioControl Medical Company Detail
11.2.2 BioControl Medical Business Overview
11.2.3 BioControl Medical Spinal Intervention Introduction
11.2.4 BioControl Medical Revenue in Spinal Intervention Business (2018-2023)
11.2.5 BioControl Medical Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Detail
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Spinal Intervention Introduction
11.3.4 Boston Scientific Corporation Revenue in Spinal Intervention Business (2018-2023)
11.3.5 Boston Scientific Corporation Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Spinal Intervention Introduction
11.4.4 Abbott Revenue in Spinal Intervention Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 Synapse Biomedical
11.5.1 Synapse Biomedical Company Detail
11.5.2 Synapse Biomedical Business Overview
11.5.3 Synapse Biomedical Spinal Intervention Introduction
11.5.4 Synapse Biomedical Revenue in Spinal Intervention Business (2018-2023)
11.5.5 Synapse Biomedical Recent Development
11.6 Zimmer Biomet Holdings
11.6.1 Zimmer Biomet Holdings Company Detail
11.6.2 Zimmer Biomet Holdings Business Overview
11.6.3 Zimmer Biomet Holdings Spinal Intervention Introduction
11.6.4 Zimmer Biomet Holdings Revenue in Spinal Intervention Business (2018-2023)
11.6.5 Zimmer Biomet Holdings Recent Development
11.7 Stryker Corporation
11.7.1 Stryker Corporation Company Detail
11.7.2 Stryker Corporation Business Overview
11.7.3 Stryker Corporation Spinal Intervention Introduction
11.7.4 Stryker Corporation Revenue in Spinal Intervention Business (2018-2023)
11.7.5 Stryker Corporation Recent Development
11.8 Orthofix International
11.8.1 Orthofix International Company Detail
11.8.2 Orthofix International Business Overview
11.8.3 Orthofix International Spinal Intervention Introduction
11.8.4 Orthofix International Revenue in Spinal Intervention Business (2018-2023)
11.8.5 Orthofix International Recent Development
11.9 Globus Medical
11.9.1 Globus Medical Company Detail
11.9.2 Globus Medical Business Overview
11.9.3 Globus Medical Spinal Intervention Introduction
11.9.4 Globus Medical Revenue in Spinal Intervention Business (2018-2023)
11.9.5 Globus Medical Recent Development
11.10 DePuy Synthes
11.10.1 DePuy Synthes Company Detail
11.10.2 DePuy Synthes Business Overview
11.10.3 DePuy Synthes Spinal Intervention Introduction
11.10.4 DePuy Synthes Revenue in Spinal Intervention Business (2018-2023)
11.10.5 DePuy Synthes Recent Development
11.11 Astellas Pharma Inc.
11.11.1 Astellas Pharma Inc. Company Detail
11.11.2 Astellas Pharma Inc. Business Overview
11.11.3 Astellas Pharma Inc. Spinal Intervention Introduction
11.11.4 Astellas Pharma Inc. Revenue in Spinal Intervention Business (2018-2023)
11.11.5 Astellas Pharma Inc. Recent Development
11.12 BioWave Corporation
11.12.1 BioWave Corporation Company Detail
11.12.2 BioWave Corporation Business Overview
11.12.3 BioWave Corporation Spinal Intervention Introduction
11.12.4 BioWave Corporation Revenue in Spinal Intervention Business (2018-2023)
11.12.5 BioWave Corporation Recent Development
11.13 Vertebral Technologies, Inc.
11.13.1 Vertebral Technologies, Inc. Company Detail
11.13.2 Vertebral Technologies, Inc. Business Overview
11.13.3 Vertebral Technologies, Inc. Spinal Intervention Introduction
11.13.4 Vertebral Technologies, Inc. Revenue in Spinal Intervention Business (2018-2023)
11.13.5 Vertebral Technologies, Inc. Recent Development
11.14 CELGENE CORPORATION
11.14.1 CELGENE CORPORATION Company Detail
11.14.2 CELGENE CORPORATION Business Overview
11.14.3 CELGENE CORPORATION Spinal Intervention Introduction
11.14.4 CELGENE CORPORATION Revenue in Spinal Intervention Business (2018-2023)
11.14.5 CELGENE CORPORATION Recent Development
11.15 Dr. Reddy's Laboratories Ltd.
11.15.1 Dr. Reddy's Laboratories Ltd. Company Detail
11.15.2 Dr. Reddy's Laboratories Ltd. Business Overview
11.15.3 Dr. Reddy's Laboratories Ltd. Spinal Intervention Introduction
11.15.4 Dr. Reddy's Laboratories Ltd. Revenue in Spinal Intervention Business (2018-2023)
11.15.5 Dr. Reddy's Laboratories Ltd. Recent Development
11.16 Endo Pharmaceuticals Inc.
11.16.1 Endo Pharmaceuticals Inc. Company Detail
11.16.2 Endo Pharmaceuticals Inc. Business Overview
11.16.3 Endo Pharmaceuticals Inc. Spinal Intervention Introduction
11.16.4 Endo Pharmaceuticals Inc. Revenue in Spinal Intervention Business (2018-2023)
11.16.5 Endo Pharmaceuticals Inc. Recent Development
11.17 Johnson & Johnson Private Limited
11.17.1 Johnson & Johnson Private Limited Company Detail
11.17.2 Johnson & Johnson Private Limited Business Overview
11.17.3 Johnson & Johnson Private Limited Spinal Intervention Introduction
11.17.4 Johnson & Johnson Private Limited Revenue in Spinal Intervention Business (2018-2023)
11.17.5 Johnson & Johnson Private Limited Recent Development
11.18 Koninklijke Philips N.V.
11.18.1 Koninklijke Philips N.V. Company Detail
11.18.2 Koninklijke Philips N.V. Business Overview
11.18.3 Koninklijke Philips N.V. Spinal Intervention Introduction
11.18.4 Koninklijke Philips N.V. Revenue in Spinal Intervention Business (2018-2023)
11.18.5 Koninklijke Philips N.V. Recent Development
11.19 Teva Pharmaceutical Industries Ltd.
11.19.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.19.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.19.3 Teva Pharmaceutical Industries Ltd. Spinal Intervention Introduction
11.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Spinal Intervention Business (2018-2023)
11.19.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.20 Merck & Co Inc.
11.20.1 Merck & Co Inc. Company Detail
11.20.2 Merck & Co Inc. Business Overview
11.20.3 Merck & Co Inc. Spinal Intervention Introduction
11.20.4 Merck & Co Inc. Revenue in Spinal Intervention Business (2018-2023)
11.20.5 Merck & Co Inc. Recent Development
11.21 Pfizer Inc
11.21.1 Pfizer Inc Company Detail
11.21.2 Pfizer Inc Business Overview
11.21.3 Pfizer Inc Spinal Intervention Introduction
11.21.4 Pfizer Inc Revenue in Spinal Intervention Business (2018-2023)
11.21.5 Pfizer Inc Recent Development
11.22 Sanofi
11.22.1 Sanofi Company Detail
11.22.2 Sanofi Business Overview
11.22.3 Sanofi Spinal Intervention Introduction
11.22.4 Sanofi Revenue in Spinal Intervention Business (2018-2023)
11.22.5 Sanofi Recent Development
11.23 SpineThera Inc.
11.23.1 SpineThera Inc. Company Detail
11.23.2 SpineThera Inc. Business Overview
11.23.3 SpineThera Inc. Spinal Intervention Introduction
11.23.4 SpineThera Inc. Revenue in Spinal Intervention Business (2018-2023)
11.23.5 SpineThera Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Medtronic
BioControl Medical
Boston Scientific Corporation
Abbott
Synapse Biomedical
Zimmer Biomet Holdings
Stryker Corporation
Orthofix International
Globus Medical
DePuy Synthes
Astellas Pharma Inc.
BioWave Corporation
Vertebral Technologies, Inc.
CELGENE CORPORATION
Dr. Reddy's Laboratories Ltd.
Endo Pharmaceuticals Inc.
Johnson & Johnson Private Limited
Koninklijke Philips N.V.
Teva Pharmaceutical Industries Ltd.
Merck & Co Inc.
Pfizer Inc
Sanofi
SpineThera Inc.
Ìý
Ìý
*If Applicable.
